Related Experiment Video
Updated: Jul 9, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan
Takashi Kohno1, Mamoru Kato1, Shinji Kohsaka1
1Center for Cancer Genomics and Advanced Therapeutics (C-CAT), National Cancer Center, Tokyo, Japan.
Insights
Japan
Area of Science:
- Oncology
- Genomics
- Health Informatics
Background:
- Japan launched national cancer genomic medicine (CGM) in June 2019.
- A network of 233 CGM hospitals and the national Center for Cancer Genomics and Advanced Therapeutics (C-CAT) were established.
- C-CAT serves as the national data center for CGM.
Purpose of the Study:
- To describe the implementation and data infrastructure of Japan's national cancer genomic medicine program.
- To highlight the role of C-CAT in collecting and reporting comprehensive genomic profiling (CGP) data.
- To inform about the accessibility of aggregated clinical and genomic data for research and development.
Main Methods:
- Comprehensive genomic profiling (CGP) tests are conducted for cancer patients.
- Clinical information and genomic data are securely transferred to C-CAT.
- C-CAT generates "C-CAT Findings" reports with clinical annotations and matched clinical trials.
Main Results:
- As of June 30, 2022, C-CAT aggregated 36,340 clinical/genomic data points.
- The number of aggregated data points is rapidly increasing.
- Data is available for sharing with CGM hospitals, academic institutions, and industries.
Conclusions:
- Japan's national CGM program, supported by C-CAT, is successfully accumulating valuable clinical and genomic data.
- The centralized data repository facilitates precision medicine initiatives.
- Open data sharing promotes further research and therapeutic advancements in oncology.
Summary:
Since June 2019, under the umbrella of the national health insurance system, Japan has started cancer genomic medicine (CGM) with comprehensive genomic profiling (CGP) tests. The Ministry of Health, Labour and Welfare (MHLW) of Japan constructed a network of CGM hospitals (a total of 233 institutes as of July 1, 2022) and established the Center for Cancer Genomics and Advanced Therapeutics (C-CAT), the national datacenter for CGM. Clinical information and genomic data from the CGP tests are securely transferred to C-CAT, which then generates "C-CAT Findings" reports containing information of clinical annotation and matched clinical trials based on the CGP data. As of June 30, 2022, a total of 36,340 datapoints of clinical/genomic information are aggregated in C-CAT, and the number is expected to increase swiftly. The data are now open for sharing with not only the CGM hospitals but also other academic institutions and industries.
Related Concept Videos
Cancer
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

